Testing the CareSens Air 3 glucose monitor in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests how accurate a new continuous glucose monitor (CGM) called CareSens Air 3 is for adults with type 1 diabetes. You would wear the sensor on your skin to track blood sugar levels, and it may help you manage your diabetes more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have type 1 diabetes and use insulin injections or an insulin pump daily for at least 3 months.
- No skin problems (like rash, tattoo, or burn) where the sensor goes.
- No severe low blood sugar in the last 3 months (passing out or seizure).
- Not pregnant, planning pregnancy, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new wearable sensor to see if it can help people with type 1 diabetes better track their blood sugar levels. It might lead to easier and more accurate glucose monitoring.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study compares a continuous glucose monitor (CGM) to fingerstick testing for people with type 1 or type 2 diabetes who give themselves insulin injections. It aims to see if using the sensor helps increase the time blood sugar stays in a healthy range.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.